Q2 2025 · 13F-HR
Foresite Capital Management V, LLCholdings as filed
Filed 2025-08-12 · accession 0001104659-25-076820
$80.7M
Reported value
6
Positions
2025-06-30
Period end
The Brief · Foresite Capital Management V, LLC · Q2 2025
AI · grounded in 13F
Foresite Capital Management V, LLC established a new position in CGON valued at $26.1M. The fund also initiated stakes in ALMS for $17.3M and IRON for $15.8M. Additional new positions include HIMS, MAZE, and LYEL, bringing the total assets under management to $80.7M across six holdings.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 156944100 | CGON | CG Oncology, Inc. | $26.1M | 32.3% | 1,004,050 | Common | SOLE |
| 022307102 | ALMS | Alumis Inc | $17.3M | 21.5% | 5,779,348 | Common | SOLE |
| 254604101 | IRON | Disc Medicine, Inc. | $15.8M | 19.6% | 299,069 | Common | SOLE |
| 433000106 | HIMS | Hims & Hers Health, Inc. | $13.6M | 16.9% | 273,151 | Common | SOLE |
| 578784100 | MAZE | Maze Therapeutics Inc | $4.2M | 5.25% | 345,191 | Common | SOLE |
| 55083R203 | LYEL | Lyell Immunopharma Inc | $3.6M | 4.45% | 406,652 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.